Mission Bio's New Single-Cell Research Platform Marries Sequencing, Cell Surface Protein Analysis
With the launch this week of its new Tapestri platform, single-cell omics firm Mission Bio is looking to make further inroads into the clinical trial and drug development businesses.
The new system adds protein measurements to the company's traditional focus on single-cell DNA sequencing, allowing researchers to make DNA and protein measurements in a single experiment and in single cells.
The system uses BioLegend's TotalSeq antibodies, which are conjugated to oligonucleotides, allowing them to be read out via single-cell sequencing. The current version of the Tapestri platform is intended for analysis of cell surface proteins, which enables researchers to identify cell type and subtype, generating data analogous to that provided by flow cytometry.
Read the full Press Release